Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.101 Q4 | 8 | 14 | 17 | 548 | 0 | 16 | 0.00 | 39.14 |  |
| 139 | EBR - European Biopharmaceutical Review | journal | 0.103 Q4 | 6 | 93 | 105 | 476 | 3 | 86 | 0.03 | 5.12 | |
| 138 | European Journal of Herbal Medicine | journal | 0.104 Q4 | 3 | 0 | 14 | 0 | 0 | 6 | 0.00 | 0.00 | |
| 137 | EPC - European Pharmaceutical Contractor | journal | 0.106 Q4 | 3 | 95 | 301 | 316 | 9 | 224 | 0.01 | 3.33 | |
| 136 | Pharmaceutical Medicine | journal | 0.108 Q4 | 25 | 43 | 81 | 829 | 8 | 59 | 0.08 | 19.28 | |
| 135 | Pharmacology Reviews and Communications | journal | 0.122 Q4 | 9 | 0 | 23 | 0 | 5 | 23 | 0.00 | 0.00 | |
| 134 | DARU, Journal of Pharmaceutical Sciences | journal | 0.126 Q4 | 58 | 32 | 97 | 790 | 23 | 96 | 0.28 | 24.69 | |
| 133 | Drug Discovery Today: Disease Models | journal | 0.130 Q4 | 33 | 48 | 64 | 1909 | 8 | 64 | 0.13 | 39.77 | |
| 132 | Journal of Drug Evaluation | journal | 0.136 Q4 | 5 | 0 | 45 | 0 | 4 | 19 | 0.09 | 0.00 | |
| 131 | Current Drug Discovery | journal | 0.146 Q4 | 13 | 0 | 401 | 0 | 74 | 233 | 0.22 | 0.00 | |
| 130 | Drug Discovery Today: Disease Mechanisms | journal | 0.156 Q4 | 28 | 81 | 65 | 3216 | 19 | 64 | 0.29 | 39.70 | |
| 129 | Pharmacy in Practice | journal | 0.170 Q4 | 6 | 85 | 134 | 515 | 13 | 111 | 0.12 | 6.06 | |
| 128 | Cutaneous and Ocular Toxicology | journal | 0.172 Q4 | 37 | 24 | 71 | 677 | 27 | 70 | 0.49 | 28.21 | |
| 127 | Toxicology Mechanisms and Methods | journal | 0.175 Q4 | 55 | 46 | 108 | 2359 | 74 | 106 | 0.75 | 51.28 | |
| 126 | IDrugs : the investigational drugs journal | journal | 0.187 Q3 | 39 | 206 | 616 | 1783 | 268 | 614 | 0.51 | 8.66 | |
| 125 | Journal of Clinical Research | journal | 0.188 Q3 | 12 | 4 | 5 | 55 | 2 | 5 | 0.67 | 13.75 | |
| 124 | Quality Assurance Journal | journal | 0.188 Q3 | 11 | 34 | 92 | 189 | 7 | 80 | 0.08 | 5.56 | |
| 123 | Journal of Applied Therapeutic Research | journal | 0.191 Q3 | 8 | 10 | 37 | 192 | 10 | 37 | 0.27 | 19.20 | |
| 122 | Drug Discovery World | journal | 0.192 Q4 | 14 | 38 | 10 | 417 | 6 | 9 | 0.60 | 10.97 | |
| 121 | Journal of Generic Medicines (discontinued) | journal | 0.192 Q3 | 16 | 47 | 54 | 444 | 11 | 48 | 0.20 | 9.45 | |
| 120 | Toxicology and Industrial Health | journal | 0.198 Q4 | 69 | 31 | 82 | 1016 | 62 | 81 | 0.26 | 32.77 | |
| 119 | International Journal of Cosmetic Science | journal | 0.199 Q3 | 77 | 32 | 99 | 886 | 80 | 99 | 0.80 | 27.69 | |
| 118 | Pharmaceutical News | journal | 0.199 Q3 | 11 | 0 | 66 | 0 | 26 | 57 | 0.00 | 0.00 | |
| 117 | Drug Discovery Today: Therapeutic Strategies | journal | 0.201 Q3 | 31 | 55 | 74 | 2069 | 38 | 73 | 0.51 | 37.62 | |
| 116 | Journal of Negative Results in BioMedicine | journal | 0.219 Q3 | 25 | 12 | 14 | 427 | 11 | 12 | 0.73 | 35.58 | |
| 115 | Pharmaceutical Journal | journal | 0.222 Q3 | 28 | 2553 | 7998 | 765 | 235 | 667 | 0.03 | 0.30 | |
| 114 | Comments on Toxicology | journal | 0.236 Q3 | 13 | 0 | 39 | 0 | 18 | 33 | 0.42 | 0.00 | |
| 113 | Toxin Reviews | journal | 0.253 Q3 | 54 | 24 | 86 | 1359 | 64 | 77 | 0.74 | 56.63 | |
| 112 | Immunopharmacology and Immunotoxicology | journal | 0.254 Q3 | 61 | 52 | 151 | 1660 | 131 | 151 | 0.69 | 31.92 | |
| 111 | BMC Chemical Biology | journal | 0.261 Q4 | 21 | 3 | 4 | 102 | 4 | 4 | 1.33 | 34.00 | |
| 110 | BMC Clinical Pharmacology | journal | 0.266 Q3 | 43 | 6 | 18 | 137 | 27 | 18 | 1.70 | 22.83 | |
| 109 | Mathematical Medicine and Biology | journal | 0.269 Q3 | 49 | 19 | 48 | 626 | 51 | 47 | 1.15 | 32.95 | |
| 108 | Pharmaceutical Biology | journal | 0.271 Q2 | 88 | 141 | 360 | 3175 | 238 | 356 | 0.53 | 22.52 | |
| 107 | Paediatric and Perinatal Drug Therapy | journal | 0.275 Q3 | 20 | 14 | 42 | 327 | 33 | 35 | 0.72 | 23.36 | |
| 106 | International Journal of Pharmacy Practice | journal | 0.278 Q2 | 44 | 34 | 101 | 977 | 68 | 100 | 0.48 | 28.74 | |
| 105 | ATLA Alternatives to Laboratory Animals | journal | 0.280 Q3 | 65 | 81 | 372 | 2954 | 317 | 343 | 0.69 | 36.47 | |
| 104 | Drugs in R and D | journal | 0.285 Q3 | 54 | 49 | 230 | 1186 | 228 | 212 | 1.18 | 24.20 | |
| 103 | Drug Design and Discovery | journal | 0.291 Q3 | 20 | 0 | 16 | 0 | 18 | 16 | 1.42 | 0.00 | |
| 102 | Autonomic and Autacoid Pharmacology | journal | 0.301 Q3 | 24 | 22 | 83 | 782 | 73 | 82 | 0.75 | 35.55 | |
| 101 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.324 Q3 | 25 | 0 | 19 | 0 | 37 | 19 | 0.00 | 0.00 | |
| 100 | Drug Discovery Today: Technologies | journal | 0.335 Q3 | 62 | 55 | 62 | 1688 | 68 | 61 | 1.10 | 30.69 | |
| 99 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.341 Q3 | 54 | 99 | 326 | 1757 | 233 | 325 | 0.73 | 17.75 | |
| 98 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | |
| 97 | Advances in Antiviral Drug Design | book series | 0.347 Q2 | 12 | 0 | 7 | 0 | 6 | 7 | 0.86 | 0.00 | |
| 96 | Expert Opinion on Drug Delivery | journal | 0.372 Q2 | 133 | 81 | 16 | 7108 | 25 | 14 | 1.56 | 87.75 | |
| 95 | Journal of Food Biochemistry | journal | 0.383 Q3 | 64 | 43 | 98 | 1452 | 86 | 98 | 0.81 | 33.77 | |
| 94 | Pharmaceutical Statistics | journal | 0.391 Q3 | 46 | 31 | 32 | 410 | 23 | 28 | 0.72 | 13.23 | |
| 93 | Journal of Chemotherapy | journal | 0.401 Q3 | 56 | 115 | 399 | 3127 | 518 | 365 | 1.20 | 27.19 | |
| 92 | Biopharmaceutics and Drug Disposition | journal | 0.403 Q2 | 65 | 51 | 136 | 1173 | 191 | 136 | 1.33 | 23.00 | |
| 91 | Drug Delivery | journal | 0.403 Q2 | 95 | 46 | 118 | 1273 | 160 | 118 | 1.28 | 27.67 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data